Robust Glucose Control and Weight Loss after Six Weeks of Treatment with MEDI0382, a Balanced GLP-1/Glucagon Receptor Dual Agonist, in Patients with Type 2 Diabetes

被引：0
|
作者：
Ambery, Philip
Stumvoll, Michael W.
Posch, Maximilian G.
Heise, Tim
Plum-Moerschel, Leona
Tsai, Lan-Feng
Robertson, Darren
Petrone, Marcella
Rondinone, Cristina
Parker, Victoria E.
Hirshberg, Boaz
Jermutus, Lutz
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-1067-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Pharmacological characterisation of MED10382, a glucagon/GLP-1 dual agonist for treatment of obesity and type 2 diabetes
    Rossi, A.
    Naylor, J.
    Will, S.
    Bhagroo, N.
    Bednarek, M. A.
    Coghlan, M. P.
    Konkar, A.
    Hornigold, D. C.
    DIABETOLOGIA, 2016, 59 : S58 - S58
  • [42] GLP-1 receptor agonist as treatment for cancer as well as diabetes: beyond blood glucose control
    Nomiyama, Takashi
    Yanase, Toshihiko
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2016, 11 (04) : 357 - 364
  • [43] Comment on "Obesity/Type 2 Diabetes: GLP-1 Agonist Tirzepatide Promotes Weight Loss"
    Blueher, Matthias
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (08) : 415 - 416
  • [44] The role of GLP-1 receptor agonists as weight loss agents in patients with and without type 2 diabetes
    Dar, Shujah
    Tahrani, Abd A.
    Piya, Milan K.
    PRACTICAL DIABETES, 2015, 32 (08) : 295 - 300
  • [45] Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus
    Christensen, Mikkel
    Knop, Filip K.
    Holst, Jens J.
    Vilsboll, Tina
    IDRUGS, 2009, 12 (08) : 503 - 513
  • [46] Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK
    Kristina S. Boye
    Dara Stein
    Louis S. Matza
    Jessica Jordan
    Ren Yu
    Kirsi Norrbacka
    Syed Wasi Hassan
    Luis-Emilio García-Pérez
    Drugs in R&D, 2019, 19 : 213 - 225
  • [47] Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK
    Boye, Kristina S.
    Stein, Dara
    Matza, Louis S.
    Jordan, Jessica
    Yu, Ren
    Norrbacka, Kirsi
    Hassan, Syed Wasi
    Garcia-Perez, Luis-Emilio
    DRUGS IN R&D, 2019, 19 (02) : 213 - 225
  • [48] Dulaglutide: A GLP-1 Receptor Agonist for Once Weekly Treatment of Type 2 Diabetes
    Heitmann, E.
    Jung, H.
    Schloot, N.
    Pavo, I.
    Forst, T.
    Trautmann, M.
    Schernthaner, G.
    DIABETOLOGIE UND STOFFWECHSEL, 2016, 11 (06) : 398 - 417
  • [49] Liraglutide. GLP-1 receptor agonist, Treatment of type 2 diabetes, Treatment of obesity
    Gallwitz, B.
    DRUGS OF THE FUTURE, 2008, 33 (01) : 13 - 20
  • [50] Effects of the GLP-1 Receptor Agonist on Fatty Liver in Patients With Type 2 Diabetes
    Ogino, Jun
    Yoneda, Chihiro
    Tajima, Kanako
    Ichimura, Yasuhiko
    Fukushima, Sayaka
    Haruki, Takenori
    Sakuma, Yukie
    Iwai, Rie
    Nishino, Takayoshi
    Suzuki, Yoshifumi
    Hashimoto, Naotake
    DIABETES, 2013, 62 : A256 - A257
12345